Skip to main content
SpringerLink
Log in

Comment on “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial”

  • Letter to the Editor
  • Published:
International Orthopaedics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Reference

  1. Zhang L, Li Y, Liu D et al (2020) Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial. Int Orthop 44(10):2079–2087

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Haitao Dong and Yali Lu contributed equally to this work.

Authors and Affiliations

  1. Department of Orthopaedics, Lanzhou University Second Hospital, Lanzhou, 730000, Gansu, China

    Haitao Dong & Yannian Luo

  2. Department of Pharmacy, Gansu Provincial Hospital, Lanzhou, 730000, Gansu, China

    Yali Lu

Authors
  1. Haitao Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yali Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yannian Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors have approved the manuscript and agree with submission.

Corresponding author

Correspondence to Haitao Dong.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Consent to participate

No consent for participation is required due to no personal data included.

Consent to publish

No consent for publication is required due to no personal data included.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dong, H., Lu, Y. & Luo, Y. Comment on “Combined use of tranexamic acid and rivaroxaban in posterior lumbar interbody fusion safely reduces blood loss and transfusion rates without increasing the risk of thrombosis-a prospective, stratified, randomized, controlled trial”. International Orthopaedics (SICOT) 45, 1903–1904 (2021). https://doi.org/10.1007/s00264-021-05036-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-021-05036-y

Search

Navigation